Target intelligence / Profile preview

ATP-dependent RNA helicase DDX19B (DDX19B)

Target
DDX19B
Molecular classification
Enzyme, RNA helicase, DEAD-box protein family
01

Overview

ATP-dependent RNA helicase DDX19B is a member of the DEAD-box protein family characterized by the conserved motif "Asp-Glu-Ala-Asp" (DEAD). It functions as an RNA helicase with ATPase activity and is involved in numerous RNA metabolic processes, particularly the export of mRNA from the nucleus to the cytoplasm. Rather than unwinding RNA duplexes in a classical sense, DDX19B remodels ribonucleoprotein particles by displacing proteins from nuclear mRNA and facilitating the loading of cytoplasmic mRNA-binding proteins. This process is essential for the regulated trafficking and maturation of mRNAs. DDX19B is recruited to the cytoplasmic fibrils of the nuclear pore complex and plays a crucial role in translation initiation, pre-mRNA splicing, ribosome assembly, and possibly other aspects of RNA metabolism. Dysfunction or altered expression of DDX19B may contribute to disease, most notably certain cancers, though the evidence for this is currently limited

Other names
DEAD-box helicase 19BDBP5DDX19RNAhTDBPDEAD5DEAD box protein 19BDEAD-box RNA helicase DEAD5DEAD box protein 5 homolog (S. cerevisiae)ATP-dependent RNA helicase DDX19DEAD (Asp-Glu-Ala-As) box polypeptide 19BDEAD (Asp-Glu-Ala-Asp) box polypeptide 19BDEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 19 (Dbp5, yeast, homolog)yeast Dbp5 homolog
02

Mechanism of action

ATP-dependent RNA unwinding Remodeling of ribonucleoprotein particles (RNPs), facilitating the replacement of nuclear mRNA-binding proteins with cytoplasmic ones during export

03

Biological functions

RNA secondary structure remodelingmRNA export from the nucleusRibosome assemblySpliceosome assemblyTranslation initiationRegulation of RNA-protein complexes
04

Disease associations

Cancer (weak associations, e.g., transitional papilloma)Other (Potential roles in diseases related to RNA metabolism are hypothesized by analogy to other DEAD-box helicases)
05

Safety considerations

Targeting enzymes involved in fundamental RNA processes may risk broad cellular toxicity and effects on essential gene expression
06

Interacting drugs

None currently documented; broadly, DEAD-box helicases are targets for inhibitors, but no approved drugs specifically targeting DDX19B are noted in the available literature and gene databases
07

Biomarkers

None specifically established for patient selection or therapeutic efficacy assessment

Beyond the preview

Go deeper on ATP-dependent RNA helicase DDX19B (DDX19B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-dependent RNA helicase DDX19B (DDX19B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call